세 개의 Etonogestrel 방출 내자宮 시스템의 안전성, 수용성 및 자궁출혈 패턴 탐구를 위한 탐구 연구 (P06060 연구)

간략 요약

This is a phase 2, randomized, active-controlled, parallel-group, multicenter, single-blind trial of three different doses of etonogestrel releasing medicated intrauterine systems (ENG-MIUS) in healthy parous women in need for contraception. The primary trial objective is to explore safety and acceptability of three doses of an ENG-releasing medicated intrauterine system (ENG-MIUS) as compared to Multiload-cu 375®.